Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Pain 6Neoplasms 6Cancer Pain 3Marijuana Abuse 2Neuralgia 1Multiple Sclerosis 1Diabetes Mellitus 1Chronic Pain 1

Interventions

nabiximols 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Marijuana Abuse × nabiximols × Clear all
NCT02073474 2022-12-20

An Observational Post-Marketing Safety Registry of Sativex®

Jazz Pharmaceuticals

Completed
978 enrolled

Marijuana Abuse, Diabetes Mellitus, Multiple Sclerosis, Neoplasms, Neuralgia

NCT03522467 2019-09-25

COPE

Aurora Cannabis Inc

Phase 2 Unknown
40 enrolled

Marijuana Abuse, Neoplasms, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡